Dual blockade of the renin-angiotensin system in diabetic nephropathy: Facts and fiction!;Double blocage du système rénine angiotensine dans la néphropathie diabétique: Faits et fictions!

Medecine des Maladies Metaboliques

Volumn 3, Issue 2, 2009, Pages 178-183

  Krummel, T ^a   Faller, A L ^a   Hannedouche, Thierry ^a  

^a UNIVERSITY HOSPITAL OF STRASBOURG   (France)

Author keywords

ACE inhibitors; Angiotensin receptor antagonists; Blood pressure; Dual blockade; Nephropathy; Proteinuria

Indexed keywords

ANGIOTENSIN 2 RECEPTOR ANTAGONIST; ANGIOTENSIN RECEPTOR ANTAGONIST; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; LOSARTAN; RAMIPRIL; TELMISARTAN; TRANDOLAPRIL;

ACUTE KIDNEY FAILURE; BLOOD PRESSURE REGULATION; CARDIOVASCULAR RISK; CHRONIC KIDNEY FAILURE; DIABETES MELLITUS; DIABETIC NEPHROPATHY; FOLLOW UP; HUMAN; HYPERTENSION; KIDNEY; MONOTHERAPY; MORBIDITY; MORTALITY; PROTEINURIA; RENIN ANGIOTENSIN ALDOSTERONE SYSTEM; REVIEW; RISK; SURVIVAL;

EID: 62249202166     PISSN: 19572557     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1957-2557(09)71633-5     Document Type: Article

References (9)

1. Azizi M, Ménard J. Combined blockade of the renin-angiotensin system with angiotensin-converting enzyme inhibitors and angiotensin II type 1 receptor antagonists. Circulation 2004;109:2492-9.
2. Azizi M, Chatellier G, Guyenne T, et al. Additive effects of combined angiotensin-converting enzyme inhibition and angiotensin II antagonism on blood pressure and renin release in sodium-depleted normotensives. Circulation 1995;92:825-34.
3. Doulton TW, He FJ, MacGregor GA. Systematic review of combined angiotensin-converting enzyme inhibition and angiotensin receptor blockade in hypertension. Hypertension 2005;45:880-6.
4. Mann JFE, Schmieder R, McQueen M, et al; ONTARGET investigators. Renal outcomes with telmisartan, ramipril, or both, in people at high vascular risk (the ONTARGET study): a multicentre, randomised, double-blind, controlled trial. Lancet 2008;372:547-53.
5. Kunz R, Friedrich C, Wolbers M, Mann JF. Meta-analysis: Effect of monotherapy and combination therapy with inhibitors of the renin-angiotensin system on proteinuria in renal disease Ann Intern Med 2008;148:30-48.
6. Jennings DL, Kalus JS, Coleman CI, et al. Combination therapy with an ACE inhibitor and an angiotensin receptor blocker for diabetic nephropathy: a meta-analysis. Diabet Med 2007;24:486-93.
7. Nakao N, Yoshimura A, Morita H, et al. Combination treatment of angiotensin-II receptor blocker and angiotensin-converting-enzyme inhibitor in non-diabetic renal disease (COOPERATE): a randomised controlled trial. Lancet 2003;361:117-24. Erratum in: Lancet 2003;361:1230.
8. Hou FF, Xie D, Zhang X, et al. Renoprotection of Optimal Antiproteinuric Doses (ROAD) study: a randomized controlled study of benazepril and losartan in chronic renal insufficiency. J Am Soc Nephrol 2007;18:1889-98.
9. Haute Autorité de Santé (HAS). Recommandation professionnelle. Moyens thérapeutiques pour ralentir la progression de l'insuffisance rénale chronique chez l'adulte. Septembre 2004. www.has-sante.fr